Annual Drug Patent Expirations for RUBRACA
Rubraca is a drug marketed by Zr Pharma and is included in one NDA. It is available from two suppliers. There are eleven patents protecting this drug.
Drug patent litigation for RUBRACA.
This drug has two hundred and six patent family members in forty-two countries.
The generic ingredient in RUBRACA is rucaparib camsylate. Two suppliers are listed for this compound. Additional details are available on the rucaparib camsylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
